Activation of the PI3K/Akt/mTOR pathway also modulates the CRC immune microenvironment by influencing cellular metabolism, promoting the survival of immunosuppressive cells, and enhancing the secretion of immunoregulatory cytokines and checkpoint molecules [185]. This evidence concerns the gene AKT1 and colorectal carcinoma.